13 June 2020 – Zwolle, The Netherlands.
The renowned European Institute for Innovation and Technology (EIT) has selected HemoClear to participate in the Bridgehead Europe programme.
In this prestigious program, the best-in-class health care innovators are connected for collaboration with the brightest minds in healthcare. During the 12 month programme HemoClear will also be granted financial support to support internationalization activities.
‘’To participate in the EIT Bridgehead program is, besides an important recognition of our blood transfusion solutions, a tremendous accelerator of our international commercialization activities,’’ says Vincent Franssen, chief executive officer at HemoClear.
We are looking forward to the upcoming Bridgehead Europe Matchmaking Event on 30 June-July 1 2020 were we will select a program partner from the Bridgehead network.